Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06128291
Other study ID # 202303052RINA
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date March 3, 2023
Est. completion date December 31, 2023

Study information

Verified date November 2023
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Compare the changes of preoperative and postoperative posterior colporrhaphy.


Description:

Introduction: Concomitant posterior colporrhaphy was frequently used during pelvic organ prolapse repair. Objectives: To evaluate the correlation between the presence of bowel symptoms and s rectocele severity and elucidate the impact of posterior colporrhaphy on bowel functions. Methods: Medical records of all consecutive women who received concomitant posterior colporrhaphy for their pelvic organ prolapse repairs were reviewed. In general, all women were requested to answer bowel incontinence assessment questionnaires before and after surgery. Possible results: Differences in rectocele severities between the presence or absence of fecal incontinence, flatus incontinence, constipation, diarrhea or sensation of residual stool will be shown.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 283
Est. completion date December 31, 2023
Est. primary completion date April 3, 2023
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 100 Years
Eligibility Inclusion Criteria: - women with pelvic organ prolapse planned to receive concomitant posterior colporrhaphy Exclusion Criteria: - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
posterior colporrhaphy
posterior colporrhaphy for rectocele.

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with fecal incontinence Number of participants present the symptom before the operation, postoperative one month and three months.
Primary Number of participants with flatus Number of patients present the symptom before the operation, postoperative one month and three months.
Primary Number of participants with constipation Number of patients present the symptom before the operation, postoperative one month and three months.
Primary Number of participants with diarrhea Number of patients present the symptom before the operation, postoperative one month and three months.
Primary Number of participants with sensation of residual stool Number of patients present the symptom before the operation, postoperative one month and three months.
See also
  Status Clinical Trial Phase
Recruiting NCT04880239 - REDUCE Trial- Reducing Prolapse Recurrence N/A
Recruiting NCT05978414 - Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology N/A
Recruiting NCT05836844 - Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women
Not yet recruiting NCT06404931 - Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment Phase 2
Completed NCT06352112 - Effects of the Hypopressive Exercises in Women With Pelvic Organ Prolapse N/A
Recruiting NCT04440475 - Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy N/A
Recruiting NCT05760794 - Barbed-suture Efficiency Study for Sacrocolpopexy N/A
Completed NCT03878056 - Cost-effectiveness Comparison Between Vaginal Versus Robotic Mesh Surgery for Apical Prolapse: Prospective, Cohort Study
Recruiting NCT05633901 - Impact of Preop Video on Patient Anxiety N/A
Completed NCT04491617 - STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial N/A
Recruiting NCT05750615 - What Affects Willingness to Self-manage a Pessary?
Not yet recruiting NCT06159777 - Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery Phase 4